Genetic mutation of OCT2 (808G→T) slowed down the elimination of metformin from kidney and improved the long‐term glucose‐lowering effect in Chinese type 2 diabetic patients 10. This evidence concerns the gene SLC22A2 and type 2 diabetes mellitus.